A Combined impedance and alphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium

Maren Pflüger, Aleksandra Kapuscik, Rudolf Lucas, Anita Koppensteiner, Michael Katzlinger, Jouni Jokela, Andreas Eger, Nico Jacobi, Christoph Wiesner, Elisabeth Hofmann, Kamil Önder, Jiri Kopecky, Wolfgang Schütt, Harald Hundsberger

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Chronic inflammation is at least partially mediated by the chemokine-mediated attraction and by the adhesion molecule-directed binding of leukocytes to the activated endothelium. Therefore, it is therapeutically important to identify anti-inflammatory compounds able to control the interaction between leukocytes and the endothelial compartments of the micro- and macrocirculation. When testing novel drug candidates, it is, however, of the utmost importance to detect side effects, such as potential cytotoxic and barrier-disruptive activities. Indeed, minor changes in the endothelial monolayer integrity may increase the permeability of small blood vessels and capillaries, which, in extreme cases, can lead to edema development. Here, we describe the development of a high-throughput screening (HTS) platform, based on AlphaLISA technology, able to identify anti-inflammatory nontoxic natural or synthetic compounds capable of reducing tumor necrosis factor (TNF)-induced chemokine (interleukin [IL]-8) and adhesion molecule (ICAM-1) expression in human lung microvascular endothelial cells. Quantification of cell membrane-expressed ICAM-1 and of cell culture supernatant-associated levels of IL-8 was analyzed in HTS. In parallel, we monitored monolayer integrity and endothelial cell viability using the electrical cell substrate impedance sensing method. This platform allowed us to identify natural secondary metabolites from cyanobacteria, capable of reducing ICAM-1 and IL-8 levels in TNF-activated human microvascular endothelial cells in the absence of endothelial monolayer barrier disruption.

Original languageEnglish (US)
Pages (from-to)67-74
Number of pages8
JournalJournal of Biomolecular Screening
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Endothelial cells
Intercellular Adhesion Molecule-1
Electric Impedance
Interleukin-8
Endothelium
Monolayers
Anti-Inflammatory Agents
Endothelial Cells
Chemokines
Screening
Leukocytes
Adhesion
Tumor Necrosis Factor-alpha
Throughput
Microcirculation
Molecules
Blood vessels
Cyanobacteria
Cell membranes
Metabolites

Keywords

  • AlphaLISA
  • ICAM-1
  • IL-8
  • chemokine
  • cyanobacteria
  • electrical cell substrate impedances sensing (ECIS)
  • high-throughput screening
  • inflammation
  • tumor necrosis factor (TNF)

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

A Combined impedance and alphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. / Pflüger, Maren; Kapuscik, Aleksandra; Lucas, Rudolf; Koppensteiner, Anita; Katzlinger, Michael; Jokela, Jouni; Eger, Andreas; Jacobi, Nico; Wiesner, Christoph; Hofmann, Elisabeth; Önder, Kamil; Kopecky, Jiri; Schütt, Wolfgang; Hundsberger, Harald.

In: Journal of Biomolecular Screening, Vol. 18, No. 1, 01.01.2013, p. 67-74.

Research output: Contribution to journalArticle

Pflüger, M, Kapuscik, A, Lucas, R, Koppensteiner, A, Katzlinger, M, Jokela, J, Eger, A, Jacobi, N, Wiesner, C, Hofmann, E, Önder, K, Kopecky, J, Schütt, W & Hundsberger, H 2013, 'A Combined impedance and alphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium', Journal of Biomolecular Screening, vol. 18, no. 1, pp. 67-74. https://doi.org/10.1177/1087057112458316
Pflüger, Maren ; Kapuscik, Aleksandra ; Lucas, Rudolf ; Koppensteiner, Anita ; Katzlinger, Michael ; Jokela, Jouni ; Eger, Andreas ; Jacobi, Nico ; Wiesner, Christoph ; Hofmann, Elisabeth ; Önder, Kamil ; Kopecky, Jiri ; Schütt, Wolfgang ; Hundsberger, Harald. / A Combined impedance and alphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. In: Journal of Biomolecular Screening. 2013 ; Vol. 18, No. 1. pp. 67-74.
@article{6a3d5e2640e24ed88710718657813817,
title = "A Combined impedance and alphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium",
abstract = "Chronic inflammation is at least partially mediated by the chemokine-mediated attraction and by the adhesion molecule-directed binding of leukocytes to the activated endothelium. Therefore, it is therapeutically important to identify anti-inflammatory compounds able to control the interaction between leukocytes and the endothelial compartments of the micro- and macrocirculation. When testing novel drug candidates, it is, however, of the utmost importance to detect side effects, such as potential cytotoxic and barrier-disruptive activities. Indeed, minor changes in the endothelial monolayer integrity may increase the permeability of small blood vessels and capillaries, which, in extreme cases, can lead to edema development. Here, we describe the development of a high-throughput screening (HTS) platform, based on AlphaLISA technology, able to identify anti-inflammatory nontoxic natural or synthetic compounds capable of reducing tumor necrosis factor (TNF)-induced chemokine (interleukin [IL]-8) and adhesion molecule (ICAM-1) expression in human lung microvascular endothelial cells. Quantification of cell membrane-expressed ICAM-1 and of cell culture supernatant-associated levels of IL-8 was analyzed in HTS. In parallel, we monitored monolayer integrity and endothelial cell viability using the electrical cell substrate impedance sensing method. This platform allowed us to identify natural secondary metabolites from cyanobacteria, capable of reducing ICAM-1 and IL-8 levels in TNF-activated human microvascular endothelial cells in the absence of endothelial monolayer barrier disruption.",
keywords = "AlphaLISA, ICAM-1, IL-8, chemokine, cyanobacteria, electrical cell substrate impedances sensing (ECIS), high-throughput screening, inflammation, tumor necrosis factor (TNF)",
author = "Maren Pfl{\"u}ger and Aleksandra Kapuscik and Rudolf Lucas and Anita Koppensteiner and Michael Katzlinger and Jouni Jokela and Andreas Eger and Nico Jacobi and Christoph Wiesner and Elisabeth Hofmann and Kamil {\"O}nder and Jiri Kopecky and Wolfgang Sch{\"u}tt and Harald Hundsberger",
year = "2013",
month = "1",
day = "1",
doi = "10.1177/1087057112458316",
language = "English (US)",
volume = "18",
pages = "67--74",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - A Combined impedance and alphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium

AU - Pflüger, Maren

AU - Kapuscik, Aleksandra

AU - Lucas, Rudolf

AU - Koppensteiner, Anita

AU - Katzlinger, Michael

AU - Jokela, Jouni

AU - Eger, Andreas

AU - Jacobi, Nico

AU - Wiesner, Christoph

AU - Hofmann, Elisabeth

AU - Önder, Kamil

AU - Kopecky, Jiri

AU - Schütt, Wolfgang

AU - Hundsberger, Harald

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Chronic inflammation is at least partially mediated by the chemokine-mediated attraction and by the adhesion molecule-directed binding of leukocytes to the activated endothelium. Therefore, it is therapeutically important to identify anti-inflammatory compounds able to control the interaction between leukocytes and the endothelial compartments of the micro- and macrocirculation. When testing novel drug candidates, it is, however, of the utmost importance to detect side effects, such as potential cytotoxic and barrier-disruptive activities. Indeed, minor changes in the endothelial monolayer integrity may increase the permeability of small blood vessels and capillaries, which, in extreme cases, can lead to edema development. Here, we describe the development of a high-throughput screening (HTS) platform, based on AlphaLISA technology, able to identify anti-inflammatory nontoxic natural or synthetic compounds capable of reducing tumor necrosis factor (TNF)-induced chemokine (interleukin [IL]-8) and adhesion molecule (ICAM-1) expression in human lung microvascular endothelial cells. Quantification of cell membrane-expressed ICAM-1 and of cell culture supernatant-associated levels of IL-8 was analyzed in HTS. In parallel, we monitored monolayer integrity and endothelial cell viability using the electrical cell substrate impedance sensing method. This platform allowed us to identify natural secondary metabolites from cyanobacteria, capable of reducing ICAM-1 and IL-8 levels in TNF-activated human microvascular endothelial cells in the absence of endothelial monolayer barrier disruption.

AB - Chronic inflammation is at least partially mediated by the chemokine-mediated attraction and by the adhesion molecule-directed binding of leukocytes to the activated endothelium. Therefore, it is therapeutically important to identify anti-inflammatory compounds able to control the interaction between leukocytes and the endothelial compartments of the micro- and macrocirculation. When testing novel drug candidates, it is, however, of the utmost importance to detect side effects, such as potential cytotoxic and barrier-disruptive activities. Indeed, minor changes in the endothelial monolayer integrity may increase the permeability of small blood vessels and capillaries, which, in extreme cases, can lead to edema development. Here, we describe the development of a high-throughput screening (HTS) platform, based on AlphaLISA technology, able to identify anti-inflammatory nontoxic natural or synthetic compounds capable of reducing tumor necrosis factor (TNF)-induced chemokine (interleukin [IL]-8) and adhesion molecule (ICAM-1) expression in human lung microvascular endothelial cells. Quantification of cell membrane-expressed ICAM-1 and of cell culture supernatant-associated levels of IL-8 was analyzed in HTS. In parallel, we monitored monolayer integrity and endothelial cell viability using the electrical cell substrate impedance sensing method. This platform allowed us to identify natural secondary metabolites from cyanobacteria, capable of reducing ICAM-1 and IL-8 levels in TNF-activated human microvascular endothelial cells in the absence of endothelial monolayer barrier disruption.

KW - AlphaLISA

KW - ICAM-1

KW - IL-8

KW - chemokine

KW - cyanobacteria

KW - electrical cell substrate impedances sensing (ECIS)

KW - high-throughput screening

KW - inflammation

KW - tumor necrosis factor (TNF)

UR - http://www.scopus.com/inward/record.url?scp=84871540580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871540580&partnerID=8YFLogxK

U2 - 10.1177/1087057112458316

DO - 10.1177/1087057112458316

M3 - Article

VL - 18

SP - 67

EP - 74

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 1

ER -